Detalhe da pesquisa
1.
Omalizumab for the Treatment of Multiple Food Allergies.
N Engl J Med
; 390(10): 889-899, 2024 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407394
2.
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
N Engl J Med
; 388(19): 1755-1766, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163622
3.
Food insecurity and allergic diseases: A call to collective action.
J Allergy Clin Immunol
; 153(2): 359-367, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926122
4.
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development.
J Allergy Clin Immunol
; 152(6): 1569-1580, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619819
5.
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
J Allergy Clin Immunol
; 152(1): 155-166.e9, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003475
6.
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Lancet
; 399(10322): 359-371, 2022 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065784
7.
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.
Blood
; 137(18): 2450-2462, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512449
8.
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans.
Allergy
; 78(3): 697-713, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089900
9.
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
J Allergy Clin Immunol
; 149(4): 1373-1382.e12, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653515
10.
Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
J Allergy Clin Immunol
; 149(6): 2166-2170.e1, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026206
11.
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
J Allergy Clin Immunol
; 149(6): 2043-2052.e9, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971646
12.
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Allergy
; 77(3): 991-1003, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320250
13.
Mapping Sequential IgE-Binding Epitopes on Major and Minor Egg Allergens.
Int Arch Allergy Immunol
; 183(3): 249-261, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818647
14.
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
J Allergy Clin Immunol
; 147(3): 992-1003.e5, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290772
15.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449234
16.
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
J Allergy Clin Immunol
; 146(4): 851-862.e10, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535135
17.
Early epitope-specific IgE antibodies are predictive of childhood peanut allergy.
J Allergy Clin Immunol
; 146(5): 1080-1088, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795587
18.
Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children.
J Allergy Clin Immunol
; 145(4): 1219-1230, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838046
19.
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
J Allergy Clin Immunol
; 146(4): 863-874, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659313
20.
Clinical factors associated with peanut allergy in a high-risk infant cohort.
Allergy
; 74(11): 2199-2211, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120555